Mass vaccination campaign following community outbreak of meningococcal disease

During December 12-29, 1998, seven patients ages 2-18 years were diagnosed with serogroup C meningococcal disease in two neighboring Florida towns with 33,000 residents. We evaluated a mass vaccination campaign implemented to control the outbreak. We maintained vaccination logs and recorded the reso...

Full description

Saved in:
Bibliographic Details
Published in:Emerging infectious diseases 2002-12, Vol.8 (12), p.1398-1403
Main Authors: Krause, Gérard, Blackmore, Carina, Wiersma, Steven, Lesneski, Cheryll, Gauch, Laurey, Hopkins, Richard S
Format: Article
Language:English
Subjects:
Adolescent
Adult
Child
Child, Preschool
Community Health Services - economics
Community Health Services - statistics & numerical data
Disease Outbreaks
Female
Florida - epidemiology
Humans
Immunization
Immunization of infants
Infant
Infants
Male
Management
Mass Vaccination - economics
Mass Vaccination - statistics & numerical data
Meningitis, Meningococcal - epidemiology
Meningitis, Meningococcal - prevention & control
Meningococcal Vaccines - administration & dosage
Meningococcal Vaccines - therapeutic use
Neisseria meningitidis
Prevention
Public health
Public Health - economics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:During December 12-29, 1998, seven patients ages 2-18 years were diagnosed with serogroup C meningococcal disease in two neighboring Florida towns with 33,000 residents. We evaluated a mass vaccination campaign implemented to control the outbreak. We maintained vaccination logs and recorded the resources used in the campaign that targeted 2- to 22-year-old residents of the two towns. A total of 13,148 persons received the vaccinations in 3 days. Vaccination coverage in the target population was estimated to be 86% to 99%. Five additional cases of serogroup C meningococcal disease occurred in the community during the year after the campaign began, four in patients who had not received the vaccine. The cost of control efforts was approximately $370,000. Although cases continued to occur, the vaccination campaign appeared to control the outbreak. Rapid implementation, a targeted approach, and high coverage were important to the campaign's success.
ISSN:1080-6040
1080-6059
DOI:10.3201/eid0812.040421